Physician profile
Roger Chen
NPI 1164786091
$6,716.89
in general payments reported to CMS, 2019-2025
28 companies · $99.58 in 2025
The $99.58 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $305 · 2021: $335 · 2022: $683 · 2023: $1,616 · 2024: $2,035 · 2025: $99.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894 · Travel and Lodging: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.55 |
| Travel and Lodging | $1,856.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,219.30 | 2019-2024 | Titan |
| Procept Biorobotics Corporation | $1,267.25 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $941.90 | 2019-2025 | Lithovue, Axonics |
| Axonics, INC. | $707.42 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $263.38 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic USA, INC. | $210.63 | 2019-2020 | |
| Abbvie INC. | $192.35 | 2022-2025 | Botox |
| Teleflex LLC | $168.07 | 2021-2024 | Urolift |
| Astellas Pharma US INC | $126.53 | 2019-2023 | Xtandi |
| Ambu INC. | $83.85 | 2022-2024 | |
| Intuitive Surgical, INC. | $72.59 | 2021-2022 | |
| Olympus America INC. | $62.82 | 2022-2024 | Itind System, Soltive |
| Endo USA, INC. | $47.00 | 2024-2025 | Xiaflex |
| Urovant Sciences INC | $40.94 | 2022 | |
| Endo Pharmaceuticals INC. | $40.46 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $39.63 | 2020 | |
| Rochester Medical Corporation | $34.06 | 2021 | |
| Laborie Medical Technologies Corp. | $25.72 | 2021-2023 | |
| Blue Earth Diagnostics | $24.91 | 2023 | |
| Baxter Healthcare | $20.55 | 2024 | Perclot |
| Calyxo, INC. | $19.74 | 2024 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $19.66 | 2024 | Adstiladrin |
| Sagent Pharmaceuticals | $18.34 | 2024 | Glydo |
| Myovant Sciences INC. | $17.27 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.10 | 2024 | |
| Urogen Pharma, INC. | $16.90 | 2023 | Jelmyto |
| Medtronic, INC. | $14.70 | 2021 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.